Device
Immunostimulating Interstitial Laser Thermotherapy
Immunostimulating Interstitial Laser Thermotherapy is a medical device with 5 clinical trials. Historical success rate of 40.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
40.0%
Based on 2 completed trials
Completion Rate
40%(2/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(60%)
Phase Distribution
Ph phase_1
1
20%
Ph not_applicable
4
80%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
N/ANon-phased studies
4(80.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
40.0%
2 of 5 finished
Non-Completion Rate
60.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Terminated(3)
Detailed Status
Terminated3
Completed2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
40.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (20.0%)
N/A4 (80.0%)
Trials by Status
terminated360%
completed240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC)
NCT02702986
terminatednot_applicable
Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma
NCT02650492
terminatednot_applicable
Immunostimulating Interstitial Laser Thermotherapy in Breast Cancer
NCT03039127
completednot_applicable
Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer
NCT02973217
terminatednot_applicable
Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers
NCT02690428
Clinical Trials (5)
Showing 5 of 5 trials
NCT02702986Phase 1
Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC)
NCT02650492Not Applicable
Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma
NCT03039127Not Applicable
Immunostimulating Interstitial Laser Thermotherapy in Breast Cancer
NCT02973217Not Applicable
Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer
NCT02690428Not Applicable
Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5